2020 Next Generation Sequencing (NGS) somatic testing (pilot)

Scheme description
Next Generation Sequencing (NGS) technical EQA for somatic testing.
Disorders/Gene target(s)
Any - From single gene panel to whole exome/genome sequencing
Clinical cases
1
Testing/analysis
Up to three data sets can be submitted per participation.
Sample type
DNA extracted from fresh-frozen tissue and matched germline DNA
Techniques
Single genes, gene panels, clinical exomes, exomes and whole genome sequencing. Three sets of data can be submitted.
Assessment
Accuracy of variant calling against the consensus sequence and a panel of NGS data quality metrics.
This is a pilot EQA so no performance criteria will be applied.
Eligibility
All laboratories worldwide
Languages
English
ISO17043 Accredited EQA
No
EQA timeline
Sample dispatchTBC
Testing periodEight weeks
Assessment resultsTBC
Final Summary reportTBC
Other information
Collaboration with EMQN
Sponsored by AstraZeneca
Fee
£620.00
GenQA code
2020NGSS
« Return to EQA scheme list
Go to top